Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15351871 | 0.97 | LMNA (0.38) | LMNA | |
| SCHEMBL15351894 | 0.97 | LMNA (0.38) | LMNA | |
| SCHEMBL7458180 | 0.97 | LMNA (0.38) | LMNA | |
| SCHEMBL1491975 | 0.97 | LMNA (0.38) | LMNA | |
| SCHEMBL15352393 | 0.97 | LMNA (0.38) | LMNA | |
| SCHEMBL5574073 | 0.97 | LMNA (0.38) | LMNA | |
| SCHEMBL5574014 | 0.90 | — | — | |
| SCHEMBL1492033 | 0.74 | — | — | |
| SCHEMBL672220 | 0.69 | LMNA (0.42) | LMNA | |
| SCHEMBL7897458 | 0.69 | LMNA (0.35) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3020715-B1 | TETRAZOLINONE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL CO (JP) | 2021-06-16 | — | — | EP | disclosed |
| EP-3059235-B1 | TETRAZOLINONE DERIVATIVES AND THEIR USE FOR CONTROLLING PESTS | SUMITOMO CHEMICAL CO (JP) | 2020-10-28 | — | — | EP | disclosed |
| EP-2841429-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PESTICIDES | SUMITOMO CHEMICAL CO (JP) | 2020-10-21 | — | — | EP | disclosed |
| EP-3040332-B1 | TETRAZOLINONE COMPOUND AND USE OF SAME | SUMITOMO CHEMICAL CO (JP) | 2020-06-03 | — | — | EP | disclosed |
| EP-2990404-B1 | TETRAZOLINONE COMPOUND AND USE OF SAME | SUMITOMO CHEMICAL CO (JP) | 2020-05-27 | — | — | EP | disclosed |
| EP-3029030-B1 | TETRAZOLINONE COMPOUND, AND USE THEREFOR | SUMITOMO CHEMICAL CO (JP) | 2019-09-04 | — | — | EP | disclosed |
| EP-3029038-B1 | TETRAZOLINONE COMPOUND AND USE THEREOF | SUMITOMO CHEMICAL CO (JP) | 2019-03-27 | — | — | EP | disclosed |
| EP-2940012-B1 | TETRAZOLINONE COMPOUND AND APPLICATIONS THEREOF | SUMITOMO CHEMICAL CO (JP) | 2019-01-30 | — | — | EP | disclosed |
| US-20180331339-A1 | POROUS MEMBRANE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-11-15 | — | — | US | disclosed |
| US-10091998-B2 | Tetrazolinone compound and use thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2018-10-09 | — | — | US | disclosed |
| US-20080103278-A1 | NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME | SUMITOMO CHEMICAL COMPANY, LIMITED | 2008-05-01 | — | — | US | disclosed |
| US-20070269747-A1 | Lithography Technique Using Silicone Molds | DOW CORNING CORPORATION | 2007-11-22 | — | — | US | disclosed |
| EP-1803033-A2 | LITHOGRAPHY TECHNIQUE USING SILICONE MOLDS | Dow Corning Corporation (US) | 2007-07-04 | — | — | EP | disclosed |
| WO-2006031455-A2 | LITHOGRAPHY TECHNIQUE USING SILICONE MOLDS | DOW CORNING CORPORATION (US) | 2006-03-23 | — | — | WO | disclosed |
| US-20050042195-A1 | New polymer and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2005-02-24 | — | — | US | disclosed |
| US-20030168656-A1 | New polymer and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED | 2003-09-11 | — | — | US | disclosed |
| EP-1318163-A1 | New polymer and polymer light-emitting device using the same | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2003-06-11 | — | — | EP | disclosed |
| EP-1001816-A4 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP (US) | 2002-07-17 | — | — | EP | disclosed |
| EP-1001816-A1 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1998023298-A1 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-06-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080103278-A1 | NEW POLYMER AND POLYMER LIGHT-EMITTING DEVICE USING THE SAME | CRY1, ARCN1, CORO1A | LMNA 679/4885 |
| US-10091998-B2 | Tetrazolinone compound and use thereof | RO60, MT-CO1, ROS1 | LMNA 3761/4885 |
| US-20050042195-A1 | New polymer and polymer light-emitting device using the same | CRY1, ARCN1, CORO1A | LMNA 679/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.